The American Association of Clinical Endocrinology has issued a grade-A recommendation to use Kerendia for certain patients with chronic kidney disease associated with type 2 diabetes.
The recommendation is part of a larger update to the AACE’s guidance on diabetes care, which includes 170 new and updated recommendations on prevention, diagnosis and treatment.
“The latest AACE guideline helps patients and their care teams better understand the treatments and resources available and equips them with the latest scientific evidence to aid critical decisions for optimal disease management,”